🔎 Trials Near Me

Utama › Neuroblastoma › Maryland

Kajian klinikal Neuroblastoma di Maryland

8 kajian untuk Neuroblastoma sedang mencari peserta di lokasi di Maryland.

Bandar di Maryland

Teks kajian rasmi (Bahasa Inggeris)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • University of Maryland/Greenebaum Cancer Center, Baltimore
  • Sinai Hospital of Baltimore, Baltimore
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
  • dan 1 lagi
Mengambil pesertaFasa 3
Sehingga umur 30 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06172296

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

  • National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
4 Weeks · Semua jantina · Dikemas kini 2 Okt 2026 · NCT01109394

Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma

  • National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaFasa 1
Umur 3 hingga 35 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06995872

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

  • National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatian
Umur 4 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT01005654

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • University of Maryland/Greenebaum Cancer Center, Baltimore
  • Sinai Hospital of Baltimore, Baltimore
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Mengambil pesertaFasa 3
365 Days – 30 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT03126916

SPEARHEAD-3 Pediatric Study

  • National Institutes of Health, Bethesda
Mengambil pesertaFasa 1/2
Umur 2 hingga 21 · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT05642455

A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

  • National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaFasa 1
Umur 18 hingga 120 · Semua jantina · Dikemas kini 15 Jun 2026 · NCT06041516

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Mengambil pesertaFasa 2
Umur 1 hingga 50 · Semua jantina · Dikemas kini 13 Mac 2026 · NCT01804634

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.